staurosporine has been researched along with Cancer of Cervix in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narayan, G; Pandey, LK; Pradhan, S; Prasad, CB; Prasad, SB; Singh, S; Yadav, SS | 1 |
| Decrion-Barthod, AZ; Launay, S; Mougin, C; Nicolier, M; Prétet, JL | 1 |
| Bosset, M; Decrion-Barthod, AZ; Launay, S; Marchini, A; Mougin, C; Nicolier, M; Plissonnier, ML; Prétet, JL; Rommelaere, J | 1 |
| Bradbury, ME; Nishi, K; Schnier, JB | 1 |
| Alfieri, AA; Sommers, GM | 1 |
| Ferenczy, A; Hao, Y; Pater, A; Tang, SC; Yang, X | 1 |
| Arun, B; Cardillo, M; Kilic, G; Ozdemirli, M | 1 |
| Bernard, B; Fest, T; Mougin, C; Prétet, JL | 1 |
8 other study(ies) available for staurosporine and Cancer of Cervix
| Article | Year |
|---|---|
Anti-tumor activity of staurosporine in the tumor microenvironment of cervical cancer: An in vitro study.
Topics: Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cervix Uteri; Down-Regulation; Enzyme Inhibitors; Female; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Poly(ADP-ribose) Polymerases; Staurosporine; Tumor Microenvironment; Uterine Cervical Neoplasms | 2015 |
Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Caspase Inhibitors; Caspases; Enzyme Activation; Female; Humans; Mutation; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2009 |
Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Female; HeLa Cells; Human papillomavirus 16; Human papillomavirus 18; Humans; Mice; Mice, Nude; Papillomavirus Infections; Staurosporine; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Cell shape change precedes staurosporine-induced stabilization and accumulation of p27kip1.
Topics: Cell Cycle; Cell Cycle Proteins; Cell Size; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cycloheximide; Cysteine Endopeptidases; Cytochalasin D; Cytoskeleton; Diacetyl; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Lung Neoplasms; Microscopy, Confocal; Multienzyme Complexes; Nucleic Acid Synthesis Inhibitors; Proteasome Endopeptidase Complex; Protein Synthesis Inhibitors; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2002 |
Multimodality therapy: radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Enzyme Inhibitors; Female; HeLa Cells; Humans; Protein Kinase C; Radiotherapy Dosage; Spheroids, Cellular; Staurosporine; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1998 |
Overexpression of anti-apoptotic gene BAG-1 in human cervical cancer.
Topics: Apoptosis; Carrier Proteins; Cervix Uteri; DNA-Binding Proteins; Female; HeLa Cells; Humans; RNA, Neoplasm; Staurosporine; Transcription Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1999 |
Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines.
Topics: Apoptosis; DNA-Binding Proteins; Female; Genes, p53; Genes, Retinoblastoma; Humans; Mitomycin; Oncogene Proteins, Viral; Staurosporine; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1999 |
Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Drug Administration Schedule; Female; Flow Cytometry; G1 Phase; G2 Phase; HeLa Cells; Human papillomavirus 18; Humans; In Situ Nick-End Labeling; Papillomavirus Infections; Staurosporine; Uterine Cervical Neoplasms | 2001 |